TREM2 and neurodegenerative disease: The identification that genetic variants in TREM2 are associated with an increased risk of AD and other neurodegenerative diseases, including PD and frontotemporal dementia (Rayaprolu et al., 2013; Cady et al., 2014), has highlighted the role of the immune response in influencing the pathogenesis of these diseases.